Literature DB >> 16687405

Smad6 represses Dlx3 transcriptional activity through inhibition of DNA binding.

Kathie A Berghorn1, Patricia A Clark-Campbell, Li Han, Michael McGrattan, Robert S Weiss, Mark S Roberson.   

Abstract

Dlx3 (Distal-less 3) is a homeobox-containing transcription factor required for normal placental development in mice. Here we demonstrate that Dlx3 interacts with Smad6, a member of a larger family of transcriptional regulators generally thought to regulate transforming growth factor beta/bone morphogenetic protein signaling. Immunocytochemical and immunoprecipitation studies demonstrate overlapping nuclear localization and physical interaction between Dlx3 and Smad6 in human choriocarcinoma cells and in differentiated trophoblasts from human placenta. In vitro protein interaction studies mapped the Smad6 interaction domain within Dlx3 to residues 80-163, a region of Dlx3 that includes a portion of the homeodomain. Dlx3 and Dlx4 share homology within this region, and Dlx4 was also found to bind Smad6. Using the Esx1 gene promoter as a model for a Dlx3-responsive gene, studies demonstrate two near consensus Dlx3 binding sites within the proximal 2.3 kb of the transcription start site. Interestingly, binding of Dlx3 to one of these two sites was inhibited by interaction with Smad6. Consistent with this result, expression of an Esx1 promoter luciferase reporter was increased by overexpression of Dlx3; this effect was reversed with co-expression of Smad6. Further, small interference RNA-mediated knockdown of endogenous Smad6 increased Dlx3-dependent expression of the Esx1 gene promoter. Thus, Smad6 appears to functionally interact with Dlx3, altering the ability of Dlx3 to bind target gene promoters. Smad6 appears to play a modulatory role in the regulation of Dlx3-dependent gene transcription within placental trophoblasts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687405     DOI: 10.1074/jbc.M603049200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  A 4 bp deletion mutation in DLX3 enhances osteoblastic differentiation and bone formation in vitro.

Authors:  Sun Jin Choi; In Sun Song; Ok Hee Ryu; Sung Won Choi; P Suzanne Hart; Wells W Wu; Rong-Fong Shen; Thomas C Hart
Journal:  Bone       Date:  2007-09-19       Impact factor: 4.398

2.  SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells.

Authors:  Hyo-Sung Jeon; Tatiana Dracheva; Sei-Hoon Yang; Daoud Meerzaman; Junya Fukuoka; Abbas Shakoori; Konstantin Shilo; William D Travis; Jin Jen
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

3.  Matrix metalloproteinase 9 is a distal-less 3 target-gene in placental trophoblast cells.

Authors:  Patricia A Clark; Jianjun Xie; Sha Li; Xuesen Zhang; Scott Coonrod; Mark S Roberson
Journal:  Am J Physiol Cell Physiol       Date:  2013-05-08       Impact factor: 4.249

4.  Distal-less 3 haploinsufficiency results in elevated placental oxidative stress and altered fetal growth kinetics in the mouse.

Authors:  P A Clark; J L Brown; S Li; A K Woods; L Han; J L Sones; R L Preston; T L Southard; R L Davisson; M S Roberson
Journal:  Placenta       Date:  2012-07-19       Impact factor: 3.481

5.  Implicating effector genes at COVID-19 GWAS loci using promoter-focused Capture-C in disease-relevant immune cell types.

Authors:  Struan F A Grant; Andrew D Wells; Matthew C Pahl; Carole Le Coz; Chun Su; Prabhat Sharma; Rajan M Thomas; James A Pippin; Emylette Cruz Cabrera; Matthew E Johnson; Michelle E Leonard; Sumei Lu; Alessandra Chesi; Kathleen E Sullivan; Neil Romberg
Journal:  Genome Biol       Date:  2022-06-03       Impact factor: 17.906

6.  Role for TGF-beta superfamily signaling in telencephalic GABAergic neuron development.

Authors:  Mario Maira; Jason E Long; Amie Y Lee; John L R Rubenstein; Stefano Stifani
Journal:  J Neurodev Disord       Date:  2009-11-27       Impact factor: 4.025

7.  Homeodomain protein DLX4 counteracts key transcriptional control mechanisms of the TGF-β cytostatic program and blocks the antiproliferative effect of TGF-β.

Authors:  B Q Trinh; N Barengo; H Naora
Journal:  Oncogene       Date:  2011-02-07       Impact factor: 9.867

8.  The Imbalance Expression of DLX3 May Perform Critical Function in the Occurrence and Progression of Preeclampsia.

Authors:  Fei Hou; Hua Jin; Luquan Cao; Xinlin Jiao; Bingyu Wang; Haiying Liu; Baoxia Cui
Journal:  Comput Math Methods Med       Date:  2022-01-21       Impact factor: 2.238

9.  Salt Dependence of DNA Binding Activity of Human Transcription Factor Dlx3.

Authors:  Ho-Seong Jin; Juyeon Son; Yeo-Jin Seo; Seo-Ree Choi; Hye-Bin Ahn; Youyeon Go; Juhee Lim; Kwang-Im Oh; Kyoung-Seok Ryu; Joon-Hwa Lee
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

10.  DLX3 interacts with GCM1 and inhibits its transactivation-stimulating activity in a homeodomain-dependent manner in human trophoblast-derived cells.

Authors:  Sha Li; Mark S Roberson
Journal:  Sci Rep       Date:  2017-05-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.